| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
Classified under Biotechnology (Health Care sector), RGNX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | - | - | |
| CEO | 338.1K | $4.43M | - | |
| Other | 206.0K | $2.00M | - | |
| Other | 205.5K | $1.99M | - | |
| CFO | 122.8K | $1.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Karabelas Argeris N73 | Director | Sale+OE10b5-1 | 10,000 | $11.56 | $115,588.00 | -47.0% | -11.8% | -13.1% | |
| Aug 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE10b5-1 | 10,100 | $13.51 | $136,454.00 | -47.2% | -33.6% | -38.5% | |
| Aug 1, 2024 | Simpson Curran64 | Chief Executive Officer | Sell10b5-1 | 100 | $15.00 | $1,500.00 | - | -33.6% | -38.5% | |
| Jul 29, 2024 | Karabelas Argeris N73 | Director | Sale+OE10b5-1 | 11,000 | $15.05 | $165,495.00 | -49.4% | -34.6% | -41.4% | |
| Jul 29, 2024 | Simpson Curran64 | Chief Executive Officer | Sell10b5-1 | 9,648 | $15.04 | $145,105.92 | -5.4% | -34.6% | -41.4% | |
| Jul 25, 2024 | Mills Kenneth T.81 | Director | Sale+OE10b5-1 | 27,590 | $13.88 | $382,934.01 | -6.3% | -32.3% | -37.7% | |
| Jul 17, 2024 | Mills Kenneth T.81 | Director | Sale+OE10b5-1 | 2,410 | $13.77 | $33,191.88 | -0.6% | -22.4% | -34.6% | |
| Jul 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE10b5-1 | 10,000 | $11.27 | $112,691.00 | -47.0% | -5.2% | -25.7% | |
| May 14, 2024 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 15,000 | $15.81 | $237,222.00 | -3.5% | -24.4% | -47.3% | |
| Apr 15, 2024 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 15,000 | $18.19 | $272,871.00 | -3.5% | -28.6% | -63.7% |